Coenzyme A-dependent metabolic enzymes (CoA-dependent enzymes)

Coenzyme A (CoA)-dependent metabolic enzymes are a broad class of proteins that utilize CoA or its thioester derivatives to facilitate critical biochemical transformations. These enzymes play fundamental roles in the tricarboxylic acid (TCA) cycle, fatty acid synthesis, and the production of cholesterol and ketone bodies [1][2]. Key members of this group, such as HMG-CoA reductase and acetyl-CoA carboxylase, serve as vital checkpoints in lipid and energy metabolism [5][6]. Dysregulation of these pathways is linked to various pathologies, including cardiovascular disease, type 2 diabetes, and non-alcoholic steatohepatitis [3][6]. In oncology, many CoA-dependent enzymes are upregulated to support the rapid proliferation and metabolic demands of cancer cells [4]. Pharmacological intervention typically involves small-molecule inhibitors designed to block the active site or allosterically regulate enzyme activity [5][7]. For example, statins inhibit HMG-CoA reductase to lower systemic cholesterol levels, while newer inhibitors target acetyl-CoA carboxylase to treat metabolic syndrome [5][6]. Therapeutic challenges include the potential for off-target effects and systemic toxicity, given the ubiquitous nature of CoA in cellular physiology [11]. Monitoring efficacy often involves measuring downstream metabolic products or circulating lipid levels [9][10]. Overall, this class of enzymes remains a cornerstone of modern pharmacology for managing metabolic health.

Other names

CoA-utilizing enzymesAcyl-CoA dependent enzymesCoenzyme A-linked enzymesCoA-dependent acyltransferases

Inhibition of enzyme catalytic activity to reduce the flux of specific metabolic pathways, such as lipid synthesis or cholesterol production, by blocking the binding of CoA or its thioester derivatives.